$ACT

Genworth Holdings, Inc. sold $25.9M of ACT

Genworth Holdings, Inc. sold 602,440 shares of Enact Holdings, Inc. (ACT) at $42.91 ($25.85M total) on 2026-05-29.

Original reporting
SEC EDGAR · Genworth Holdings, Inc.
Published Jun 1, 2026, 8:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 8:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACT
Neutral
medium confidence
Mentioned
$ACT
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACTNeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity (additional sales or buys) and compare with broader price/volume action, but the filing itself is not a fundamental update.

02

Market read

A sizable 10% owner sale (~$25.85M) is a sentiment/positioning datapoint that can add short-term volatility but lacks fundamental context.

03

What to watch

Form 4 timing reflects disclosure lag; without details on motivations or whether other insiders are buying, the signal strength is limited.

Relevance 7/10Novelty 6/10Timing: Disclosure filed 2026-06-01 after the 2026-05-29 sale

Background

SEC Form 4 reports a 10% owner’s transaction in the issuer’s shares; this filing documents an open-market sale.

Company-level read

Ticker impact

$ACTNeutralMedium confidence
Context

Genworth Holdings (10% owner) filed an open-market sale of 602,440 ACT shares for ~$25.85M on 2026-05-29, per SEC Form 4.

Expected impact

Slight-to-moderate near-term downside bias or volatility around the disclosure; magnitude likely limited absent other fundamentals.

Evidence & confidence

This is a disclosed ownership reduction (602,440 shares) with no 10b5-1 plan indicated, but insider sales alone rarely drive sustained moves without corroborating company-specific catalysts.

Market effects

Minimal sector read-through; this is company-specific ownership activity rather than industry/regulatory change.

None indicated.

None indicated.

Counterpoint

The sale may be driven by liquidity/tax/portfolio rebalancing rather than a view on ACT fundamentals, especially given the large remaining position.

Key entities

  • Enact Holdings, Inc.

    ACT is the company whose shares were sold by a 10% owner, disclosed via SEC Form 4.

  • Genworth Holdings, Inc.

    Reported as the seller executing an open-market sale of ACT shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACTMedAI 8/10

Enact (ACT) Q2 2026 Earnings Call Transcript

Enact (ACT) reported Q2 2026 adjusted operating income of $177 million, or $1.26 per diluted share, up from $174 million, or $1.15, in Q2 2025. New insurance written rose 15% to $15 billion. FY2026 capital return guidance was raised to $550 million to $600 million. Management cited $274 billion insurance in force and 161% PMIERs sufficiency.